Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity

Key Points

• Urokinase plasminogen activator is linked to early metabolic regulation in obesity.
• Key evidence indicates that elevated levels of this biomarker correlate with obesity rates.
• Observational analysis highlights the potential role of fibrinolytic pathways in obesity management.
• Findings suggest new therapeutic approaches targeting urokinase for obesity treatment.